CATHERINE EHRENBERGER

Profile

First Name

: CATHERINE

Middle Name

:

Last Name

: EHRENBERGER

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-29